- Home
- PHAR vs SSYS Comparison
PHAR vs SSYS Comparison
Compare PHAR & SSYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- SSYS
- Stock Information
- Founded
- PHAR 1988
- SSYS 1989
- Country
- PHAR Netherlands
- SSYS United States
- Employees
- PHAR N/A
- SSYS N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- SSYS Computer peripheral equipment
- Sector
- PHAR Health Care
- SSYS Technology
- Exchange
- PHAR Nasdaq
- SSYS Nasdaq
- Market Cap
- PHAR 627.5M
- SSYS 634.6M
- IPO Year
- PHAR N/A
- SSYS 1994
- Fundamental
- Price
- PHAR $9.98
- SSYS $8.98
- Analyst Decision
- PHAR Strong Buy
- SSYS Strong Buy
- Analyst Count
- PHAR 3
- SSYS 4
- Target Price
- PHAR $27.00
- SSYS $11.50
- AVG Volume (30 Days)
- PHAR 6.0K
- SSYS 468.3K
- Earning Date
- PHAR 03-13-2025
- SSYS 03-06-2025
- Dividend Yield
- PHAR N/A
- SSYS N/A
- EPS Growth
- PHAR N/A
- SSYS N/A
- EPS
- PHAR N/A
- SSYS N/A
- Revenue
- PHAR $285,745,000.00
- SSYS $578,436,000.00
- Revenue This Year
- PHAR $20.08
- SSYS N/A
- Revenue Next Year
- PHAR $9.22
- SSYS $3.22
- P/E Ratio
- PHAR N/A
- SSYS N/A
- Revenue Growth
- PHAR 30.64
- SSYS N/A
- 52 Week Low
- PHAR $6.65
- SSYS $6.05
- 52 Week High
- PHAR $13.20
- SSYS $14.22
- Technical
- Relative Strength Index (RSI)
- PHAR 56.13
- SSYS 47.18
- Support Level
- PHAR $9.37
- SSYS $8.36
- Resistance Level
- PHAR $10.15
- SSYS $9.10
- Average True Range (ATR)
- PHAR 0.50
- SSYS 0.44
- MACD
- PHAR -0.09
- SSYS -0.04
- Stochastic Oscillator
- PHAR 57.53
- SSYS 45.26
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.
About SSYS Stratasys Ltd. (Israel)
Stratasys Ltd is a polymer-based 3D printing solution, which provides a product life cycle, with multiple technologies and complete solutions for superior application fit, across industrial, healthcare, and consumer fields. It focuses, in particular, on polymer 3D printing solutions that address the fastest-growing manufacturing solutions viewed as the potential growth opportunity in the 3D printing industry. Its printers include FDM, PolyJet, Stereolithography, P3, and SAF. Its software is GrabCAD Software, Connectivity, Digital Anatomy Creator, and OpenAM Software. It generates revenue through 3D printing systems, related services, and consumables and by providing additive manufacturing solutions.